BHVN Deadline: Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

(NYSE:BHVN) NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025. Biohaven describes itself as a “biopharmaceutical company that discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-36